Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1961 1
1962 3
1963 1
1964 4
1965 1
1966 2
1967 2
1968 3
1969 3
1971 2
1972 1
1974 6
1975 3
1976 6
1977 5
1978 3
1980 3
1981 4
1982 6
1983 15
1984 10
1985 17
1986 15
1987 5
1988 13
1989 19
1990 9
1991 12
1992 18
1993 13
1994 11
1995 14
1996 14
1997 15
1998 25
1999 22
2000 20
2001 22
2002 10
2003 12
2004 9
2005 14
2006 11
2007 10
2008 13
2009 9
2010 9
2011 11
2012 9
2013 7
2014 4
2015 11
2016 9
2017 10
2018 7
2019 4
2020 4
2022 7
2023 7
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

526 results

Results by year

Filters applied: . Clear all
Page 1
Mechanisms and management of loss of response to anti-TNF therapy for patients with Crohn's disease: 3-year data from the prospective, multicentre PANTS cohort study.
Chanchlani N, Lin S, Bewshea C, Hamilton B, Thomas A, Smith R, Roberts C, Bishara M, Nice R, Lees CW, Sebastian S, Irving PM, Russell RK, McDonald TJ, Goodhand JR, Ahmad T, Kennedy NA; PANTS Consortium. Chanchlani N, et al. Lancet Gastroenterol Hepatol. 2024 Jun;9(6):521-538. doi: 10.1016/S2468-1253(24)00044-X. Epub 2024 Apr 16. Lancet Gastroenterol Hepatol. 2024. PMID: 38640937 Free article.
Allopurinol and cardiovascular outcomes in patients with ischaemic heart disease: the ALL-HEART RCT and economic evaluation.
Mackenzie IS, Hawkey CJ, Ford I, Greenlaw N, Pigazzani F, Rogers A, Struthers AD, Begg AG, Wei L, Avery AJ, Taggar JS, Walker A, Duce SL, Barr RJ, Dumbleton JS, Rooke ED, Townend JN, Ritchie LD, MacDonald TM; ALL-HEART Study Group. Mackenzie IS, et al. Among authors: hawkey cj. Health Technol Assess. 2024 Mar;28(18):1-55. doi: 10.3310/ATTM4092. Health Technol Assess. 2024. PMID: 38551218 Free PMC article. Clinical Trial.
Safety and efficacy of autologous haematopoietic stem-cell transplantation with low-dose cyclophosphamide mobilisation and reduced intensity conditioning versus standard of care in refractory Crohn's disease (ASTIClite): an open-label, multicentre, randomised controlled trial.
Lindsay JO, Hind D, Swaby L, Berntsson H, Bradburn M, Bannur C U, Byrne J, Clarke C, Desoysa L, Dickins B, Din S, Emsley R, Foulds GA, Gribben J, Hawkey C, Irving PM, Kazmi M, Lee E, Loban A, Lobo A, Mahida Y, Moran GW, Papaioannou D, Parkes M, Peniket A, Pockley AG, Satsangi J, Subramanian S, Travis S, Turton E, Uttenthal B, Rutella S, Snowden JA. Lindsay JO, et al. Among authors: hawkey c. Lancet Gastroenterol Hepatol. 2024 Apr;9(4):333-345. doi: 10.1016/S2468-1253(23)00460-0. Epub 2024 Feb 7. Lancet Gastroenterol Hepatol. 2024. PMID: 38340759 Free article. Clinical Trial.
Autologous stem cell transplantation with low-dose cyclophosphamide to improve mucosal healing in adults with refractory Crohn’s disease: the ASTIClite RCT.
Lindsay JO, Hind D, Swaby L, Berntsson H, Bradburn M, Bannur C U, Byrne J, Clarke C, Desoysa L, Din S, Emsley R, Foulds GA, Gribben J, Hawkey C, Irving PM, Johnson P, Kazmi M, Lee E, Loban A, Lobo A, Mahida Y, Moran G, Papaioannou D, Parkes M, Peniket A, Pockley AG, Satsangi J, Subramanian S, Travis S, Turton E, Uttenthal B, Rutella S, Snowden JA. Lindsay JO, et al. Among authors: hawkey c. Southampton (UK): National Institute for Health and Care Research; 2024 Jan. Southampton (UK): National Institute for Health and Care Research; 2024 Jan. PMID: 38408175 Free Books & Documents. Review.
Baseline Expression of Immune Gene Modules in Blood is Associated With Primary Response to Anti-TNF Therapy in Crohn's Disease Patients.
Bai BYH, Reppell M, Smaoui N, Waring JF, Pivorunas V, Guay H, Lin S, Chanchlani N, Bewshea C, Goodhand JR, Kennedy NA, Ahmad T, Anderson CA; UK Inflammatory Bowel Disease Pharmacogenetics Study Group. Bai BYH, et al. J Crohns Colitis. 2024 Mar 1;18(3):431-445. doi: 10.1093/ecco-jcc/jjad166. J Crohns Colitis. 2024. PMID: 37776235 Free PMC article.
HLA-DP on Epithelial Cells Enables Tissue Damage by NKp44+ Natural Killer Cells in Ulcerative Colitis.
Baumdick ME, Niehrs A, Degenhardt F, Schwerk M, Hinrichs O, Jordan-Paiz A, Padoan B, Wegner LHM, Schloer S, Zecher BF, Malsy J, Joshi VR, Illig C, Schröder-Schwarz J, Möller KJ; Hamburg Intestinal Tissue Study Group; Martin MP, Yuki Y, Ozawa M, Sauter J, Schmidt AH, Perez D, Giannou AD, Carrington M, Davis RS, Schumacher U, Sauter G, Huber S, Puelles VG, Melling N, Franke A; International Inflammatory Bowel Disease Genetics Consortium; Altfeld M, Bunders MJ. Baumdick ME, et al. Gastroenterology. 2023 Oct;165(4):946-962.e13. doi: 10.1053/j.gastro.2023.06.034. Epub 2023 Jul 15. Gastroenterology. 2023. PMID: 37454979 Free article.
Genome-Wide Methylation Profiling in 229 Patients With Crohn's Disease Requiring Intestinal Resection: Epigenetic Analysis of the Trial of Prevention of Post-operative Crohn's Disease (TOPPIC).
Ventham NT, Kennedy NA, Kalla R, Adams AT, Noble A, Ennis H; TOPPIC Study Group; IBD-BIOM Consortium; Mowat C, Dunlop MG, Satsangi J. Ventham NT, et al. Cell Mol Gastroenterol Hepatol. 2023;16(3):431-450. doi: 10.1016/j.jcmgh.2023.06.001. Epub 2023 Jun 17. Cell Mol Gastroenterol Hepatol. 2023. PMID: 37331566 Free PMC article. Clinical Trial.
526 results